2021 Biotech Stock Picking Charity Contest Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : 2021 Biotech Stock Picking Charity Contest

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Aloner who wrote (95)	1/28/2021 2:02:53 PM
From: Arthur Radley	of 307

This article about remdesivir, Gilead's drug, is going to open a can of worms. What is the answer--why should taxpayers pay more than $3,000.00 for using this drug if India can produce it for $300.00? Remdesivir, Given to Half of Hospitalized Covid Patients in U.S., Is Big Win for Gilead — Boosted by Taxpayers \| Kaiser Health News (khn.org)

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next